The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boon, A. C. M.
Right arrow Articles by Rimmelzwaan, G. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boon, A. C. M.
Right arrow Articles by Rimmelzwaan, G. F.
The Journal of Immunology, 2004, 172: 4435-4443.
Copyright © 2004 by The American Association of Immunologists

Preferential HLA Usage in the Influenza Virus-Specific CTL Response1

Adrianus C. M. Boon*, Gerrie de Mutsert*, Ron A. M. Fouchier*, Kees Sintnicolaas{dagger}, Albert D. M. E. Osterhaus* and Guus F. Rimmelzwaan2,*

* Department of Virology and World Health Organization National Influenza Center, Erasmus Medical Center, Rotterdam, The Netherlands; and {dagger} Sanquin Bloodbank Rotterdam, Laboratory for Histocompatibility and Immunogenetics, Dordrecht, The Netherlands

To study whether individual HLA class I alleles are used preferentially or equally in human virus-specific CTL responses, the contribution of individual HLA-A and -B alleles to the human influenza virus-specific CTL response was investigated. To this end, PBMC were obtained from three groups of HLA-A and -B identical blood donors and stimulated with influenza virus. In the virus-specific CD8+ T cell population, the proportion of IFN-{gamma}- and TNF-{alpha}-producing cells, restricted by individual HLA-A and -B alleles, was determined using virus-infected C1R cells expressing a single HLA-A or -B allele for restimulation of these cells. In HLA-B*2705- and HLA-B*3501-positive individuals, these alleles were preferentially used in the influenza A virus-specific CTL response, while the contribution of HLA-B*0801 and HLA-A*0101 was minor in these donors. The magnitude of the HLA-B*0801-restricted response was even lower in the presence of HLA-B*2705. C1R cells expressing HLA-B*2705, HLA-A*0101, or HLA-A*0201 were preferentially lysed by virus-specific CD8+ T cells. In contrast, the CTL response to influenza B virus was mainly directed toward HLA-B*0801-restricted epitopes. Thus, the preferential use of HLA alleles depended on the virus studied.




This article has been cited by other articles:


Home page
CVIHome page
A. Palikhe, M.-L. Lokki, P. Saikku, M. Leinonen, M. Paldanius, M. Seppanen, V. Valtonen, M. S. Nieminen, and J. Sinisalo
Association of Chlamydia pneumoniae Infection with HLA-B*35 in Patients with Coronary Artery Disease
Clin. Vaccine Immunol., January 1, 2008; 15(1): 55 - 59.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. A. Wojcechowskyj, L. J. Yant, R. W. Wiseman, S. L. O'Connor, and D. H. O'Connor
Control of Simian Immunodeficiency Virus SIVmac239 Is Not Predicted by Inheritance of Mamu-B*17-Containing Haplotypes
J. Virol., January 1, 2007; 81(1): 406 - 410.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. C. M. Boon, G. de Mutsert, R. A. M. Fouchier, A. D. M. E. Osterhaus, and G. F. Rimmelzwaan
The Hypervariable Immunodominant NP418-426 Epitope from the Influenza A Virus Nucleoprotein Is Recognized by Cytotoxic T Lymphocytes with High Functional Avidity.
J. Virol., June 1, 2006; 80(12): 6024 - 6032.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Bihl, N. Frahm, L. Di Giammarino, J. Sidney, M. John, K. Yusim, T. Woodberry, K. Sango, H. S. Hewitt, L. Henry, et al.
Impact of HLA-B Alleles, Epitope Binding Affinity, Functional Avidity, and Viral Coinfection on the Immunodominance of Virus-Specific CTL Responses
J. Immunol., April 1, 2006; 176(7): 4094 - 4101.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.